These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 29948260)

  • 1. Predictors of Patient-Reported Dysphagia Following IMRT Plus Chemotherapy in Oropharyngeal Cancer.
    Orlandi E; Miceli R; Infante G; Mirabile A; Alterio D; Cossu Rocca M; Denaro N; Vigna-Taglianti R; Merlotti A; Schindler A; Pizzorni N; Fallai C; Licitra L; Bossi P
    Dysphagia; 2019 Feb; 34(1):52-62. PubMed ID: 29948260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting two-year longitudinal MD Anderson Dysphagia Inventory outcomes after intensity modulated radiotherapy for locoregionally advanced oropharyngeal carcinoma.
    Goepfert RP; Lewin JS; Barrow MP; Fuller CD; Lai SY; Song J; Hobbs BP; Gunn GB; Beadle BM; Rosenthal DI; Garden AS; Kies MS; Papadimitrakopoulou VA; Schwartz DL; Hutcheson KA
    Laryngoscope; 2017 Apr; 127(4):842-848. PubMed ID: 27440393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term, Prospective Performance of the MD Anderson Dysphagia Inventory in "Low-Intermediate Risk" Oropharyngeal Carcinoma After Intensity Modulated Radiation Therapy.
    Goepfert RP; Lewin JS; Barrow MP; Gunn GB; Fuller CD; Beadle BM; Garden AS; Rosenthal DI; Kies MS; Papadimitrakopoulou V; Lai SY; Gross ND; Schwartz DL; Hutcheson KA
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(4):700-708. PubMed ID: 27485284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long term patient reported swallowing function following chemoradiotherapy for oropharyngeal carcinoma.
    Dixon L; Ramasamy S; Cardale K; Dyker K; Garcez K; Lee LW; McPartlin A; Murray P; Sen M; Slevin N; Sykes A; Prestwich R; Thomson D
    Radiother Oncol; 2018 Sep; 128(3):452-458. PubMed ID: 29937211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in Patient-reported Swallow Function in the Long Term After Chemoradiotherapy for Oropharyngeal Carcinoma.
    Martin A; Murray L; Sethugavalar B; Buchan C; Williams GF; Sen M; Prestwich RJD
    Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):756-763. PubMed ID: 30025978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicities affecting quality of life after chemo-IMRT of oropharyngeal cancer: prospective study of patient-reported, observer-rated, and objective outcomes.
    Hunter KU; Schipper M; Feng FY; Lyden T; Haxer M; Murdoch-Kinch CA; Cornwall B; Lee CS; Chepeha DB; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):935-40. PubMed ID: 23040224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysphagia-optimised intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in patients with head and neck cancer (DARS): a phase 3, multicentre, randomised, controlled trial.
    Nutting C; Finneran L; Roe J; Sydenham MA; Beasley M; Bhide S; Boon C; Cook A; De Winton E; Emson M; Foran B; Frogley R; Petkar I; Pettit L; Rooney K; Roques T; Srinivasan D; Tyler J; Hall E;
    Lancet Oncol; 2023 Aug; 24(8):868-880. PubMed ID: 37423227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-item discrimination of quality-of-life-altering dysphagia among 714 long-term oropharyngeal cancer survivors: Comparison of patient-reported outcome measures of swallowing.
    ; Grant S; Kamal M; Mohamed ASR; Zaveri J; Barrow MP; Gunn GB; Lai SY; Lewin JS; Rosenthal DI; Wang XS; Fuller CD; Hutcheson KA
    Cancer; 2019 May; 125(10):1654-1664. PubMed ID: 30633325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Objective Ratings of Swallowing and Dysphagia-Specific Quality of Life in Patients Receiving (Chemo)radiotherapy for Oropharyngeal Cancer.
    Wishart LR; Harris GB; Cassim N; Alimin S; Liao T; Brown B; Ward EC; Nund RL
    Dysphagia; 2022 Aug; 37(4):1014-1021. PubMed ID: 34625841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results.
    Feng FY; Kim HM; Lyden TH; Haxer MJ; Worden FP; Feng M; Moyer JS; Prince ME; Carey TE; Wolf GT; Bradford CR; Chepeha DB; Eisbruch A
    J Clin Oncol; 2010 Jun; 28(16):2732-8. PubMed ID: 20421546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of radiation dose to pharyngeal constrictor muscles on late dysphagia and quality of life in patients with locally advanced oropharyngeal carcinoma.
    Mogadas S; Busch CJ; Pflug C; Hanken H; Krüll A; Petersen C; Tribius S
    Strahlenther Onkol; 2020 Jun; 196(6):522-529. PubMed ID: 32006068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-volume toxicity modeling for de-intensified chemo-radiation therapy for HPV-positive oropharynx cancer.
    Mavroidis P; Price A; Fried D; Kostich M; Amdur R; Mendenhall W; Liu C; Das S; Marks LB; Chera B
    Radiother Oncol; 2017 Aug; 124(2):240-247. PubMed ID: 28712533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-reported outcomes following parotid-sparing intensity-modulated radiotherapy for head and neck cancer. How important is dysphagia?
    Roe JW; Drinnan MJ; Carding PN; Harrington KJ; Nutting CM
    Oral Oncol; 2014 Dec; 50(12):1182-7. PubMed ID: 25448227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspiration pneumonia after chemo-intensity-modulated radiation therapy of oropharyngeal carcinoma and its clinical and dysphagia-related predictors.
    Hunter KU; Lee OE; Lyden TH; Haxer MJ; Feng FY; Schipper M; Worden F; Prince ME; McLean SA; Wolf GT; Bradford CR; Chepeha DB; Eisbruch A
    Head Neck; 2014 Jan; 36(1):120-5. PubMed ID: 23729173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term quality of life after swallowing and salivary-sparing chemo-intensity modulated radiation therapy in survivors of human papillomavirus-related oropharyngeal cancer.
    Vainshtein JM; Moon DH; Feng FY; Chepeha DB; Eisbruch A; Stenmark MH
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):925-33. PubMed ID: 25832685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-Reported Outcomes After Swallowing (SWOARs)-Sparing IMRT in Head and Neck Cancers: Primary Results from a Prospective Study Endorsed by the Head and Neck Study Group (HNSG) of the Italian Association of Radiotherapy and Clinical Oncology (AIRO).
    Ursino S; Calistri E; De Felice F; Bonomo P; Desideri I; Franco P; Arcadipane F; Colosimo C; Mazzola R; Maddalo M; Gonnelli A; Malfatti G; Morganti R; Musio D; Paiar F
    Dysphagia; 2023 Feb; 38(1):159-170. PubMed ID: 35587295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional swallowing outcomes following transoral robotic surgery vs primary chemoradiotherapy in patients with advanced-stage oropharynx and supraglottis cancers.
    More YI; Tsue TT; Girod DA; Harbison J; Sykes KJ; Williams C; Shnayder Y
    JAMA Otolaryngol Head Neck Surg; 2013 Jan; 139(1):43-8. PubMed ID: 23247974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Swallowing-related outcomes associated with late lower cranial neuropathy in long-term oropharyngeal cancer survivors: cross-sectional survey analysis.
    Aggarwal P; Zaveri JS; Goepfert RP; Shi Q; Du XL; Swartz M; Lai SY; Fuller CD; Lewin JS; Piller LB; Hutcheson KA
    Head Neck; 2019 Nov; 41(11):3880-3894. PubMed ID: 31441572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of selective neck dissection on chronic dysphagia after chemo-intensity-modulated radiotherapy for oropharyngeal carcinoma.
    Hutcheson KA; Abualsamh AR; Sosa A; Weber RS; Beadle BM; Sturgis EM; Lewin JS
    Head Neck; 2016 Jun; 38(6):886-93. PubMed ID: 26339764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective evaluation of patient reported swallow function with the Functional Assessment of Cancer Therapy (FACT), MD Anderson Dysphagia Inventory (MDADI) and the Sydney Swallow Questionnaire (SSQ) in head and neck cancer patients.
    Peng LC; Hui X; Cheng Z; Bowers MR; Moore J; Cecil E; Choflet A; Thompson A; Muse M; Kiess AP; Page BR; Gourin CG; Fakhry C; Szczesniak M; Maclean J; Wu P; Cook I; McNutt TR; Quon H
    Oral Oncol; 2018 Sep; 84():25-30. PubMed ID: 30115472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.